We are live on ! Find out more
JNJ icon

Johnson & Johnson

2,756 hedge funds and large institutions have $252B invested in Johnson & Johnson in 2019 Q2 according to their latest regulatory filings, with 91 funds opening new positions, 1,129 increasing their positions, 1,289 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 91 | Existing positions closed: 66

4.93% more ownership

Funds ownership: 68.05%72.98% (+4.9%)

0% less funds holding

Funds holding: 2,7662,756 (-10)

0% less capital invested

Capital invested by funds: $253B → $252B (-$1.14B)

7% less funds holding in top 10

Funds holding in top 10: 690639 (-51)

11% less call options, than puts

Call options by funds: $1.69B | Put options by funds: $1.9B

12% less repeat investments, than reductions

Existing positions increased: 1,129 | Existing positions reduced: 1,289

Holders
2,756
Holders Change
-10
Holders Change %
-0.36%
% of All Funds
59.85%
Holding in Top 10
639
Holding in Top 10 Change
-51
Holding in Top 10 Change %
-7.39%
% of All Funds
13.88%
New
91
Increased
1,129
Reduced
1,289
Closed
66
Calls
$1.69B
Puts
$1.9B
Net Calls
-$208M
Net Calls Change
+$260M
Name Holding Trade Value Shares
Change
Change in
Stake
RA
501
Rovida Advisors
Florida
$23.4M
BC
502
Blackhill Capital
New Jersey
$23.3M
RE
503
RBC Europe
United Kingdom
$23.3M +$172K +1,245 +0.8%
MPWT
504
MassMutual Private Wealth & Trust
Connecticut
$23.2M +$447K +3,230 +2%
SIM
505
Sentry Investment Management
Wisconsin
$23.2M -$3.28M -23,695 -12%
WTC
506
WhitTier Trust Company
Nevada
$23M -$262K -1,890 -1%
MHC
507
Meyer Handelman Company
New York
$22.8M -$263K -1,900 -1%
GAM
508
Guinness Asset Management
United Kingdom
$22.8M +$3.96M +28,612 +21%
CC
509
Cornerstone Capital
California
$22.6M -$481K -3,477 -2%
RJT
510
Raymond James Trust
Florida
$22.5M +$770K +5,561 +4%
GI
511
GAMCO Investors
Connecticut
$22.5M +$2.26M +16,345 +11%
DWM
512
Doyle Wealth Management
Florida
$22.4M -$14.9K -108 -0.1%
DWA
513
Douglass Winthrop Advisors
New York
$22.3M -$372K -2,689 -2%
VWM
514
Valley Wealth Managers
New Jersey
$22.3M +$499K +3,605 +2%
AAIM
515
Asset Advisors Investment Management
Georgia
$22.3M +$124K +896 +0.6%
SPIA
516
Steward Partners Investment Advisory
New York
$22.2M -$1.91M -13,779 -8%
ZIC
517
ZWJ Investment Counsel
Georgia
$22.1M +$528K +3,816 +2%
Rockefeller Capital Management
518
Rockefeller Capital Management
New York
$22M -$2.14M -15,446 -9%
CIC
519
Carnegie Investment Counsel
Ohio
$21.9M -$17.7K -128 -0.1%
GT
520
Glenview Trust
Kentucky
$21.9M -$211K -1,525 -1%
TCM
521
Twin Capital Management
Pennsylvania
$21.8M -$8.8M -63,549 -29%
WPC
522
Waters Parkerson & Co
Louisiana
$21.8M -$684K -4,941 -3%
COPPSERS
523
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$21.7M +$24.5K +177 +0.1%
CIA
524
Capital Investment Advisors
Georgia
$21.6M +$33.5K +242 +0.2%
ABTD
525
Arvest Bank Trust Division
Oklahoma
$21.6M -$669K -4,836 -3%

JNJ Hedge Fund Activity: Q2 2019 in Review

2,756 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2019, worth a combined $252B — down 0.45% from $253B a quarter earlier.

Buyers outnumbered sellers: 91 funds opened new JNJ positions and 66 closed out — a net gain of 25 holders — while 1,129 added to existing stakes and 1,289 trimmed.

The largest buyer was Phocas Financial Corp, adding an estimated $17.3B. The largest seller was Barrow, Hanley, Mewhinney & Strauss, cutting an estimated $719M.

  • 2,756 institutional investors held Johnson & Johnson (JNJ) as of Q2 2019, down from 2,766 in Q1 2019.
  • Funds reported $252B of Johnson & Johnson stock for Q2 2019, down 0.45% quarter-over-quarter.
  • 91 funds opened new Johnson & Johnson positions in Q2 2019 and 66 closed out, a net change of +25 holders.
  • The largest Johnson & Johnson buyer in Q2 2019 was Phocas Financial Corp, an estimated $17.3B added.
  • The largest Johnson & Johnson seller in Q2 2019 was Barrow, Hanley, Mewhinney & Strauss, an estimated $719M sold.

Based on aggregated 13F filings for Q2 2019.